Wiley Matthew T. Insider Trading -- Recent SEC Form 4 Transactions
Wiley Matthew T. (CIK 1759703) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-29). Recent activity: Sell DFTX (3,097 shares), Buy DFTX (125,000 shares), Buy DFTX (62,500 shares), Sell DFTX (2,867 shares), Buy DFTX (62,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-29 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | Sell | 3,097 | $113,257 |
| 2026-09-14 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | Buy | 125,000 | $0 |
| 2026-08-12 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | Buy | 62,500 | $0 |
| 2026-06-26 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | Sell | 2,867 | $129,101 |
| 2026-06-22 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | Buy | 62,500 | $0 |
| 2026-02-05 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | Buy | 115,000 | $0 |
Source: SEC Form 4 filings · as of 2026-09-29